A case of acute myelogenous leukaemia characterised by the BCR-FGFR1 translocation

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Matikas, Alexios ^a   Tzannou, Ifigeneia ^a   Oikonomopoulou, Dimitra ^a   Bakiri, Maria ^a  

^a IASO GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BREAKPOINT CLUSTER REGION PROTEIN; CYTARABINE; ETOPOSIDE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FLUDARABINE; HYDROXYUREA; IDARUBICIN; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; BLOOD CELL COUNT; CASE REPORT; CHROMOSOME 22; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FUSION GENE; HUMAN; LABORATORY TEST; LEUKOCYTOSIS; MULTIPLE CYCLE TREATMENT; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 84877300436     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-008834     Document Type: Article

References (18)

1. Feng L, Young-Ping Z, Yu-Mei T, et al. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer 2012;51:890-7.
2. Fioretos T, Panagopoulos I, Lassen C, et al. Fusion of the BCR and the fibroblast growth factor Receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL. Genes Chromosomes Cancer 2001;32:302-10. (Pubitemid 33055115)
3. Wakim J, Tirado C, Chen W, et al. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature. Leuk Res 2011;35:e151-3.
4. Haslam K, Langabeer S, Kelly J, et al. Allogeneic hematopoietic stem cell transplantation for a BCR-FGFR1 myeloproliferative neoplasm presenting as acute lymphoblastic leukemia. Case Report Hematol 2012;2012:620967.
5. Baldazzi C, Iacobucci I, Luatti S, et al. B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCRFGFR1 fusion gene. Leuk Res 2010;34:e282-5.
6. Dong S, Kang S, Gu TL, et al. 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1 - transformed hematopoietic cells. Blood 2007;110:360-9. (Pubitemid 47026855)
7. Jackson CC, Medeiros LJ, Miranda RN. 8p11 myeloproliferative syndrome: a review. Hum Pathol 2010;41:461-76.
8. Morishige S, Oku E, Takata Y, et al. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation. Acta Haematol 2012;129:83-9.
9. Kantarjian HM, Keating MJ, Walters RS, et al. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. J Clin Oncol 1986;4:1748.
10. Demiroglou A, Steer J, Heath C, et al. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood 2001;98:3778-83.
11. Gotlib J. World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management. Am J Hematol 2011;86:677-88.
12. Cortes JE, Kantarjian H, Shah NP, et al. Ponatinib in refractory Philadelphia chromosome-positive leukemias. N Engl J Med 2012;367:2075-88.
13. Ren M, Qin H, Ren R, et al. Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities. Leukemia 2013;27:32-40.
14. Ming Qiang R, Tidwell J, Sharma S, et al. Acute progression of BCR-FGFR1 induced murine B lympho/myeloproliferative disorder suggests involvement of lineages at the Pro-B cell stage. PLoS ONE 2012;7:e38265.
15. Pini M, Gottardi E, Scaravaglio P, et al. A fourth case of BCR-FGFR1 positive CML-like disease with t(8;22) translocation showing an extensive deletion on the derivative chromosome 8p. Hematol J 2002;3:315-16. (Pubitemid 36163760)
16. Murati A, Arnoulet C, Lafage-Pochitaloff M, et al. Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion. Int J Oncol 2005;26:1485-92.
17. Agerstam H, Lilljebjörn H, Lassen C, et al. Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer 2007;46:635-43. (Pubitemid 46802330)
18. Richebourg S, Theisen O, Plantier I, et al. Chronic myeloproliferative disorder with t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic chronic myelogeneous leukemia. Genes Chromosomes Cancer 2008;47:915-18.